In the latest effort by the Trump administration to reduce costs and increase access to anti-obesity medications like Ozempic ...
New funding through FHWA aims to help states and local agencies advance bridge rehabilitation while expanding access for ...
The Centers for Medicare and Medicaid extended the Bridge program, which makes GLP-1s for obesity available for $50, through the end of 2027.
Learn who qualifies for Medicare’s GLP-1 Bridge, when $50 Wegovy and Zepbound access begins, and key rules beneficiaries need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results